TQB2858
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TQB2858, covering 2021-11-30 to 2022-01-21. Get the full timeline:
Most recent: Clinical Trial Update: To Evaluate the Safety and Efficacy of TQB2858 Injection to the Subjects With Recurrent/Metastatic Nasopharyngeal Cancer [Phase 1, Phase 2]